The Use of Cerium Oxide and Curcumin Nanoparticles as Therapeutic Agents for the Treatment of Ventricular Hypertrophy Following Pulmonary Arterial Hypertension

Chinthalapally V. Rao, Regulation of COX and LOX by curcumin. Advances in Experimental Medicine and Biology. ,vol. 595, pp. 213- 226 ,(2007) , 10.1007/978-0-387-46401-5_9

H Hjorth Tønnesen, Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. Die Pharmazie. ,vol. 57, pp. 820- 824 ,(2002)

Pavol Joppa, Darina Petrášová, Branislav Stančák, Zuzana Dorková, Ružena Tkáčová, Oxidative stress in patients with COPD and pulmonary hypertension. Wiener Klinische Wochenschrift. ,vol. 119, pp. 428- 434 ,(2007) , 10.1007/S00508-007-0819-Y

Pan Mh, Cheng Al, Jee Sh, Lin Br, Ho Yf, Chen Ca, Pu Ys, Chen Gs, Ko Jy, Hsu Mm, Ming-Shiang W, Shen Ts, Wang Yj, Chen Tm, Tsai Cc, Hsu Ch, Lin Jk, Yu Hs, Lin Jt, Lai Mk, Hsieh Cy, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research. ,vol. 21, pp. 2895- 2900 ,(2001)

Ronald J Oudiz, Bruce H Brundage, Nazzareno Galiè, Hossein Ardeschir Ghofrani, Gerald Simonneau, Fady T Botros, Melanie Chan, Anthony Beardsworth, Robyn J Barst, PHIRST Study Group, Tadalafil for the Treatment of Pulmonary Arterial Hypertension: A Double-Blind 52-Week Uncontrolled Extension Study Journal of the American College of Cardiology. ,vol. 60, pp. 768- 774 ,(2012) , 10.1016/J.JACC.2012.05.004

Nipa R. Shah, Richard Stringham, Pulmonary arterial hypertension: an update on diagnosis and treatment. American Family Physician. ,vol. 82, pp. 370- 377 ,(2010)

Sumitra Miriyala, Manikandan Panchatcharam, Puvanakrishnan Rengarajulu, Cardioprotective effects of curcumin. Advances in Experimental Medicine and Biology. ,vol. 595, pp. 359- 377 ,(2007) , 10.1007/978-0-387-46401-5_16

Dorrah D. Deeb, George Divine, Xiaohua Gao, Subhash C. Gautam, Scott A. Dulchavsky, Hao Jiang, Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. Journal of Experimental Therapeutics and Oncology. ,vol. 5, pp. 81- 91 ,(2005)

S H Francis, J D Corbin, Pharmacology of phosphodiesterase-5 inhibitors. International Journal of Clinical Practice. ,vol. 56, pp. 453- 459 ,(2002)

Kyle D. Weaver, Susan Yeyeodu, James C. Cusack, Jr., Albert S. Baldwin, Jr., Matthew G. Ewend, Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas Journal of Neuro-oncology. ,vol. 61, pp. 187- 196 ,(2003) , 10.1023/A:1022554824129